About

Umoja Biopharma is developing an integrated platform therapeutics that reprograms T cells in vivo to target and eliminate cancer cells, with a focus on treating solid tumors and hematological cancers. Their in-house CAR T-cell gene therapy platform is designed to work in vivo to treat solid tumors and hematologic malignancies at all stages.